Navigation Links
Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable,Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical,Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma

eb site at www.accentia.net.

Forward-Looking Statements

Statements in this release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, statements about Revimmune(TM) SinuNase(TM), BiovaxID(TM), AutovaxID(TM), CRSFungal Profile(TM) and any other statements relating to products, product candidates, product development programs the FDA or clinical study process including the commencement, process or completion of clinical trials or the regulatory process. Such statements may include, without limitation, statements with respect to the Company's plans, objectives, expectations and intentions and other statements identified by words such as "may," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results of Accentia to be materially different from historical results or from any results expressed or implied by such forward-looking statements. These factors include, but are not limited to, risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for product candidates; competition from other pharmaceutical or biotechnology companies; and the additional risks discussed in filings with the Securities and Exchange Commission. All forward-looking statements are qualified in their entirety by this cautionary statement, and Accentia undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof.

Contact

Biovest International, Inc., New York, NY
Steven Arikian, MD
Chairman and Chief Executive Officer
212-686-4100 ext 8640





Page: 1 2 3 4 5

Related medicine technology :

1. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
2. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
3. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
4. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
5. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
6. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
7. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
8. Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer Patients Treated with Therapy Based on Ratiometric Dosing
9. Eloxatin (oxaliplatin injection)-Based Chemotherapy Sets New Treatment Benchmark in Patients With Metastatic Colorectal Cancer
10. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
11. Othera Pharmaceuticals Announces Upcoming Presentation Based Upon Expanded Understanding of Lead Compound Mechanism of Action

Post Your Comments:
(Date:11/6/2009)..., Nov. 6 California American Water...o Drugs Down the Drain" week for its San Diego Cou...onsored by public and private agencies alike towar...llution in our source water supplies. ,, Califo...re encouraged to drop off expired or unwanted phar...
(Date:11/5/2009)..., N.J., Nov. 5 Osteotech...field of biologic products for regenerative healin...quarter ended September 30, 2009. ,, "During th...ase of our three new biologic products MagniFuse(...d Plexur M® Innovative Grafting," said Sam Ow...
(Date:11/5/2009)...HMOND, Calif., Nov. 5 Tr...specialty pharmaceutical company focused on the de...ducts that address important therapeutic needs in ... host a webcast and teleconference with management...n Thursday, November 12, 2009, at 5:00 p.m. Easter...
Breaking Medicine Technology:California American Water Celebrates 'No Drugs Down the Drain' Week in San Diego 2Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2New Test Assesses Individual Breast Cancer Risk 58896 1New Test Assesses Individual Breast Cancer Risk 58896 2New Test Assesses Individual Breast Cancer Risk 58896 3Antidepressants May Be Linked to Birth Problems 58893 1Antidepressants May Be Linked to Birth Problems 58893 2VBI awarded 2427 million from NIH to support infectious disease research 10266 1VBI awarded 2427 million from NIH to support infectious disease research 10266 2VBI awarded 2427 million from NIH to support infectious disease research 10266 3VBI awarded 2427 million from NIH to support infectious disease research 10266 4
...ORK, June 13, 2007--Three new drugs for,rheumatoid...ment,for this difficult and debilitating condition...udy published early Online and in an,upcoming edit...chronic,inflammatory joint diseases, affecting 0&m...alised world. Its typical symptoms are,joint pain,...
... TIKVA, Israel--(BUSINESS WIRE)--Jun 14, 2007 - Ca...any traded on the Tel,Aviv Stock Exchange Exchange...CF502; this is in addition to CF101, which is curr...eclinical phases. This,weekend Can-Fite will prese...-vitro and in vivo study results showing effective...
Other Medicine Technology:Three New Drugs Mark New Era in Rheumatoid Arthritis Treatment 2Three New Drugs Mark New Era in Rheumatoid Arthritis Treatment 3Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2
(Date:11/8/2009)...HINGTON, Nov. 7 USActio...alth Care for America Act, which will make health ... companies accountable and increase access to heal... option. ,, "Teddy Roosevelt, FDR and Harry Tru...r Alan Charney. "Today,s vote ranks among our coun...
(Date:11/8/2009)...lls for Swift Passage of H.R. 3961 to Secure the S...swire-USNewswire/ -- Statement Attributable to: J....ssociation. ,, (Logo: http://www.newscom.com/...ails the passage of the House health reform bill, ...ents and physicians and calls for swift passage of...
(Date:11/8/2009)...RP Praises House Passage of Health Care Reform Bil...dicare, improve coverage for all Americans ,, ...the United States House of Representatives passed ...legislation that would strengthen Medicare for sen... that prices millions of Americans out of affordab...
(Date:11/8/2009)...RP Praises House Passage of Health Care Reform Bil...dicare, improve coverage for all Americans ,, ...ARY: Tonight the United States House of Represent...ion that would strengthen Medicare for seniors and...ices millions of Americans out of affordable healt...
(Date:11/7/2009)...HINGTON, Nov. 7 Karen I...rance Plans (AHIP), released the following stateme...lth plans strongly support comprehensive health ca...ion by proposing a complete overhaul of how health...osed guaranteed coverage, elimination of pre-exist...
Breaking Medicine News(10 mins):Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2
...Explores Psychological, Social, Physical and Educa...IL (PRWEB) January 5, 2009 -- Since the advent of ...onger game play, two things have occurred in the v...nies, over what effect videos games have on childr...
...anuary 13, 2009 , 10:00 a.m. Eastern Standard Time... , Locations of Initial Recruitment , , WASHING...ional Institutes of Health: , , What: A media t...nited States, the National Children,s study will f...
...ection Saves Pets , Kansa...u commit to your new year,s resolutions or not, ve... Center of Kansas City are urging you to commit t... lead to a loved one,s life saved and less costly ...
...rging technologies can create environments that re...e University researcher thinks games like Nintendo...edentary activities for people of all ages. , "I ...department of kinesiology at K-State and director ...
...mming from the catastrophic,October 15, 2008 crash...nois,was filed today on behalf of Robert and Brook...r 14-month-old daughter Kirstin Reann Blockinger. ...al,Hospital hit a radio tower and its supporting s...
...harmaceuticals, Inc. (Nasdaq: ONXX ) today annou...hts to SB1518, an orally available, potent, and se...1578, also a JAK2 inhibitor, from S*BIO Pte Ltd ba...yx as ONX 0803) and SB1578 (designated by Onyx as ...
Other Medicine News:Health News:Psychiatrist Examines Effects of Video Game Play on Children 2Health News:Psychiatrist Examines Effects of Video Game Play on Children 3Health News:Telebriefing: National Children's Study Recruitment Begins 2Health News:Tips on When to Bring Pets to Animal ER 2Health News:Tips on When to Bring Pets to Animal ER 3Health News:Wii Fit a promising tool for all ages 2Health News:Wii Fit a promising tool for all ages 3Health News:Nolan Law Group Files Lawsuit on Behalf of the Parents of a 14-Month-Old Girl Killed in October 15th 2008 Medical Evacuation Helicopter Crash Near Aurora, Illinois 2Health News:Nolan Law Group Files Lawsuit on Behalf of the Parents of a 14-Month-Old Girl Killed in October 15th 2008 Medical Evacuation Helicopter Crash Near Aurora, Illinois 3Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 2Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 3Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 4
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: